Ceftolozane + Tazobactam for Injection 1 g + 0.5 g Suppliers & Bulk Manufacturers
Available Forms: Powder for concentrate vial (IV infusion)
Available Strengths: 1 g + 0.5 g
Pack Sizes: Packs of 10 vials
Originator reference: Zerbaxa (MSD) (brand names belong to their owners and are shown only to identify the originator medicine)
Category: Antibiotics
Ceftolozane-tazobactam (Zerbaxa, MSD) is a hospital antibiotic with strong activity against multidrug-resistant Pseudomonas aeruginosa, used for complicated urinary and abdominal infections and hospital-acquired pneumonia. PharmaTradz handles enquiries for authorised supply of the originator product (named-patient and import-permit orders), and connects developers and licensees preparing for patent and exclusivity expiry.
Manufacture or export Ceftolozane + Tazobactam for Injection? List it or send an offer →
Product Description:
Ceftolozane is a cephalosporin designed to resist the defence mechanisms of Pseudomonas aeruginosa, one of the hardest hospital bacteria to treat. Tazobactam is added to block many extended-spectrum beta-lactamases. Together they often remain active against Pseudomonas strains that are resistant to carbapenems, piperacillin-tazobactam and ceftazidime.
It is approved for complicated urinary tract infections, complicated intra-abdominal infections (with metronidazole) and hospital-acquired or ventilator-associated pneumonia. It is given by intravenous infusion every eight hours; the pneumonia dose is double the standard dose. It does not cover carbapenemase-producing bacteria, so susceptibility testing guides its use.
Sourcing notes. Ceftolozane-tazobactam is protected by patents in major markets and is supplied by the originator. Hospitals in countries where it is not registered can often import it through named-patient or special-access routes. Ceftazidime-avibactam and meropenem-vaborbactam are also listed on PharmaTradz.
Handling, dosing and buyer checklist
Storage and preparation. Vials are stored in a refrigerator at 2–8°C and protected from light. Each vial is reconstituted with 10 mL of water for injection or sodium chloride 0.9% and then diluted in 100 mL for a one-hour infusion.
How it is given. The usual dose is 1.5 g (one vial) every 8 hours for urinary and abdominal infections, and 3 g (two vials) every 8 hours for hospital-acquired or ventilator-associated pneumonia, with lower doses when kidney function is reduced. Treatment usually lasts 4 to 14 days, guided by culture results.
What to ask a supplier. Proof that the product is the authorised originator supply, the registration status or import route for the destination, cold-chain shipping with temperature records, remaining shelf life, and pack size. For hospital formularies, ask about local susceptibility data before ordering larger quantities.
How Ceftolozane + Tazobactam for Injection is supplied today, and licensing ahead of patent expiry
Frequently Asked Questions
Complicated urinary and intra-abdominal infections and hospital-acquired pneumonia, especially when multidrug-resistant Pseudomonas is involved.
Zerbaxa, from MSD. Each vial contains 1 g ceftolozane and 0.5 g tazobactam.
Generally no. Its strength is resistant Pseudomonas; carbapenemase producers usually need other agents.
Not in major markets. We handle authorised-supply and special-import enquiries and connect developers preparing for patent expiry.
Related Products
Ceftazidime + Avibactam for Injection
Strength:
2 g + 0.5 g
Form: Powder for concentrate vial (IV infusion)
Originator reference: Zavicefta, Avycaz
View DetailsMeropenem + Vaborbactam for Injection
Strength:
1 g + 1 g
Form: Powder for concentrate vial (IV infusion)
Originator reference: Vabomere (US), Vaborem (EU)
View DetailsDelamanid Tablets
Strength:
50 mg; 25 mg dispersible (paediatric)
Form: Film-coated tablets, dispersible tablets
Originator reference: Deltyba (Otsuka)
View DetailsPolymyxin B for Injection
Strength:
500,000 IU (50 mg)
Form: Lyophilised powder vial (IV, IM, intrathecal)
Originator reference:
View DetailsCeftazidime + Sulbactam Injection
Strength:
1500mg
Form: Injection
Originator reference: -
View DetailsCefoperazone Sodium Injection
Strength:
250mg, 500mg, 1000mg
Form: Injection
Originator reference: Cefobid
View DetailsRoxithromycin Tablet
Strength:
150mg
Form: Tablets
Originator reference: Rulid (EU), Surlid (EU)
View DetailsCefadroxil / Lactic Acid Bacillus Tablet
Strength:
250mg, 100 mg
Form: Tablets
Originator reference: -
View DetailsUsually answered within 48 hours | GMP documents shared before you commit